small sized icon representing the Cardiovascular area of interest
Cardiorenal
small sized icon representing the Hematology area of interest
Hematología
small sized icon representing the Ophthalmology area of interest
Oftalmología
small sized icon representing the Oncology area of interest
Oncología
small sized icon representing the Women's Health area of interest
Salud de la Mujer
SPACETu portal médico
Apalutamide, Darolutamide and Enzalutamide for nmCRPC
Ir al contenido
Oncología

Apalutamide, Darolutamide and Enzalutamide for Nonmetastatic Castration-Resistant Prostate Cancer (nmCRPC): A Critical Review

Cattrini, C.; Caffo, O. et al.Cancers 2022, 14, 1792. https://doi.org/10.3390/cancers14071792

Related Content
Guías EAU 2023
Cáncer de próstata
Darolutamide and Survival in mHSPC
CPHSm
Darolutamide + ADT + Docetaxel in mHSPC by Subgroups
CPHSm